NDC 54473-184-01 - CounterAct Night

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
54473-184
Requested NDC
54473-184-01
Package NDCs from labels
54473-184-01, 54473-184-36
Manufacturer
Melaleuca, Inc.
Effective date
2019-12-09
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
CounterAct Night Content of LabelMelaleuca, Inc.2019-12-09HUMAN OTC DRUG LABEL

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ACETAMINOPHENACTIVE INGREDIENT362O9ITL9DCOUNTERACT NIGHT (ACETAMINOPHEN, DIPHENYDRAMINE HCI, PHENYLEPHRINE HCI) TABLET, COATED [MELALEUCA, INC.]1
DIPHENHYDRAMINE HYDROCHLORIDEACTIVE INGREDIENTTC2D6JAD40COUNTERACT NIGHT (ACETAMINOPHEN, DIPHENYDRAMINE HCI, PHENYLEPHRINE HCI) TABLET, COATED [MELALEUCA, INC.]1
PHENYLEPHRINE HYDROCHLORIDEACTIVE INGREDIENT04JA59TNSJCOUNTERACT NIGHT (ACETAMINOPHEN, DIPHENYDRAMINE HCI, PHENYLEPHRINE HCI) TABLET, COATED [MELALEUCA, INC.]1
ACETAMINOPHENACTIVE MOIETY362O9ITL9DCOUNTERACT NIGHT (ACETAMINOPHEN, DIPHENYDRAMINE HCI, PHENYLEPHRINE HCI) TABLET, COATED [MELALEUCA, INC.]1
DIPHENHYDRAMINEACTIVE MOIETY8GTS82S83MCOUNTERACT NIGHT (ACETAMINOPHEN, DIPHENYDRAMINE HCI, PHENYLEPHRINE HCI) TABLET, COATED [MELALEUCA, INC.]1
PHENYLEPHRINEACTIVE MOIETY1WS297W6MVCOUNTERACT NIGHT (ACETAMINOPHEN, DIPHENYDRAMINE HCI, PHENYLEPHRINE HCI) TABLET, COATED [MELALEUCA, INC.]1
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UCOUNTERACT NIGHT (ACETAMINOPHEN, DIPHENYDRAMINE HCI, PHENYLEPHRINE HCI) TABLET, COATED [MELALEUCA, INC.]1
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH48COUNTERACT NIGHT (ACETAMINOPHEN, DIPHENYDRAMINE HCI, PHENYLEPHRINE HCI) TABLET, COATED [MELALEUCA, INC.]1
CROSPOVIDONEINACTIVE INGREDIENT68401960MKCOUNTERACT NIGHT (ACETAMINOPHEN, DIPHENYDRAMINE HCI, PHENYLEPHRINE HCI) TABLET, COATED [MELALEUCA, INC.]1
FD&C BLUE NO. 1INACTIVE INGREDIENTH3R47K3TBDCOUNTERACT NIGHT (ACETAMINOPHEN, DIPHENYDRAMINE HCI, PHENYLEPHRINE HCI) TABLET, COATED [MELALEUCA, INC.]1
HYDROXYPROPYL CELLULOSEINACTIVE INGREDIENTRFW2ET671PCOUNTERACT NIGHT (ACETAMINOPHEN, DIPHENYDRAMINE HCI, PHENYLEPHRINE HCI) TABLET, COATED [MELALEUCA, INC.]1
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WOCOUNTERACT NIGHT (ACETAMINOPHEN, DIPHENYDRAMINE HCI, PHENYLEPHRINE HCI) TABLET, COATED [MELALEUCA, INC.]1
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30COUNTERACT NIGHT (ACETAMINOPHEN, DIPHENYDRAMINE HCI, PHENYLEPHRINE HCI) TABLET, COATED [MELALEUCA, INC.]1
POLYETHYLENE GLYCOLINACTIVE INGREDIENT3WJQ0SDW1ACOUNTERACT NIGHT (ACETAMINOPHEN, DIPHENYDRAMINE HCI, PHENYLEPHRINE HCI) TABLET, COATED [MELALEUCA, INC.]1
POVIDONEINACTIVE INGREDIENTFZ989GH94ECOUNTERACT NIGHT (ACETAMINOPHEN, DIPHENYDRAMINE HCI, PHENYLEPHRINE HCI) TABLET, COATED [MELALEUCA, INC.]1
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4COUNTERACT NIGHT (ACETAMINOPHEN, DIPHENYDRAMINE HCI, PHENYLEPHRINE HCI) TABLET, COATED [MELALEUCA, INC.]1
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJCOUNTERACT NIGHT (ACETAMINOPHEN, DIPHENYDRAMINE HCI, PHENYLEPHRINE HCI) TABLET, COATED [MELALEUCA, INC.]1
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APCOUNTERACT NIGHT (ACETAMINOPHEN, DIPHENYDRAMINE HCI, PHENYLEPHRINE HCI) TABLET, COATED [MELALEUCA, INC.]1
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPCOUNTERACT NIGHT (ACETAMINOPHEN, DIPHENYDRAMINE HCI, PHENYLEPHRINE HCI) TABLET, COATED [MELALEUCA, INC.]1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 4 of 369 · 7,368 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
HemorrhoidalMINERAL OIL, PETROLATUM, PHENYLEPHRINE HCLShield Line LLC5f627926-b8de-c02a-e063-6294a90aa7a52026-11-03WarningsExact identifier
unii: 04JA59TNSJ
Dolex ForteACETAMINOPHEN, ASPIRIN, CAFFEINEPharmadel LLC3c2d90fc-130d-476c-e063-6294a90a8c152026-11-03WarningsExact identifier
unii: 362O9ITL9D
hemorrhoidalGLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUMShield Line LLC5f635795-cb5b-cab4-e063-6394a90a7a9a2026-11-03WarningsExact identifier
unii: 04JA59TNSJ
VICKS FORMULA 44DM NIGHTTIME COUGH and COLDACETAMINOPHEN, DEXTROMETHORPHAN HBR, CHLORPHENIRAMINE MALEATEProcter & Gamble Manufacturing Company05414779-f61d-8fa7-e063-6394a90aa0342026-11-03WarningsExact identifier
unii: 362O9ITL9D
MULTI-SYMPTOM COLDDEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCLFamily Dollar Services Incb1fae7cc-4033-44bc-aa7c-ca3ceea51c7d2026-11-03WarningsExact identifier
unii: 04JA59TNSJ
AcetaminophenACETAMINOPHENRugby Laboratoriesb16ed4ef-689c-4df2-ab6c-207aa8b9925d2026-11-02WarningsExact identifier
unii: 362O9ITL9D
acetaminophenACETAMINOPHENREMEDYREPACK INC.dc430980-5994-4e61-ad3d-181f5fdc769d2026-11-02WarningsExact identifier
unii: 362O9ITL9D
LoHist DMBROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE AND PHENYLEPHRINE HYDROCHLORIDELarken Laboratories, Inc.29730dab-fa09-4351-9b36-0359ba4f77442026-11-02WarningsExact identifier
unii: 04JA59TNSJ
EndaCof DMBROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE AND PHENYLEPHRINE HYDROCHLORIDELarken Laboratories, Inc.c68ea55a-8b9a-4a70-8b5c-1a27366518132026-11-02WarningsExact identifier
unii: 04JA59TNSJ
NoHist DMCHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE AND PHENYLEPHRINE HYDROCHLORIDELarken Laboratories, Inc.6aafe912-28ff-442f-8e07-b3c5993ac9432026-11-02WarningsExact identifier
unii: 04JA59TNSJ
Acetaminophen PM Extra StrengthACETAMINOPHEN, DIPHENHYDRAMINE HCLARMY AND AIR FORCE EXCHANGE SERVICEf1157dbc-d86c-4554-954c-60a74674ff6b2026-11-02WarningsExact identifier
unii: TC2D6JAD40
unii: 362O9ITL9D
equate pain relieverACETAMINOPHENWALMART INC.59d01f72-4575-48e2-b914-b6a6456ca7d22026-11-02WarningsExact identifier
unii: 362O9ITL9D
HERA SILKYSTAY FOUNDATION 34W1TITANIUM DIOXIDEAmorepacific Corporation5f3ef340-c68e-1790-e063-6394a90a44aa2026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 35C1TITANIUM DIOXIDEAmorepacific Corporation5f40c97f-b90e-bec7-e063-6394a90ae5db2026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 35N1TITANIUM DIOXIDEAmorepacific Corporation5f40f46b-c6b2-df1f-e063-6394a90afd962026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 37W1TITANIUM DIOXIDEAmorepacific Corporation5f4105f3-d08b-edb5-e063-6394a90ad28b2026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 39N1TITANIUM DIOXIDEAmorepacific Corporation5f41120a-521a-f5ac-e063-6394a90ac0212026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 41W1TITANIUM DIOXIDEAmorepacific Corporation5f4158f0-c743-29c2-e063-6394a90ac7212026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 43N1TITANIUM DIOXIDEAmorepacific Corporation5f41ecb2-9fe5-ade7-e063-6294a90abc4e2026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 43O1TITANIUM DIOXIDEAmorepacific Corporation5f425415-ed84-fc33-e063-6394a90a15f72026-11-01WarningsExact identifier
unii: 15FIX9V2JP

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.